{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T00:23:51Z","timestamp":1789604631028,"version":"build-2803163510"},"reference-count":38,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2004,1,1]],"date-time":"2004-01-01T00:00:00Z","timestamp":1072915200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinics in Dermatology"],"published-print":{"date-parts":[[2004,1]]},"DOI":"10.1016\/j.clindermatol.2003.11.005","type":"journal-article","created":{"date-parts":[[2004,5,29]],"date-time":"2004-05-29T13:36:16Z","timestamp":1085837776000},"page":"34-39","source":"Crossref","is-referenced-by-count":53,"title":["Botulinum toxin types A and B: comparison of efficacy, duration, and dose-ranging studies for the treatment of facial rhytides and hyperhidrosis"],"prefix":"10.1016","volume":"22","author":[{"given":"Paul S","family":"Yamauchi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas J","family":"Lowe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clindermatol.2003.11.005_BIB1","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1097\/00006534-199902000-00055","article-title":"Botox for the treatment of dynamic and hyperkinetic facial lines and furrows","volume":"103","author":"Fagien","year":"1999","journal-title":"Plast Reconstr Surg"},{"key":"10.1016\/j.clindermatol.2003.11.005_BIB2","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1001\/archderm.125.8.1090","article-title":"The microanatomical basis of facial frown lines","volume":"125","author":"Pierard","year":"1989","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2003.11.005_BIB3","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1056\/NEJM199104253241707","article-title":"Therapeutic uses of botulinum toxin","volume":"324","author":"Jankovic","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clindermatol.2003.11.005_BIB4","doi-asserted-by":"crossref","first-page":"616","DOI":"10.7326\/0003-4819-125-7-199610010-00013","article-title":"Botulinum toxin","volume":"125","author":"Simpson","year":"1996","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.clindermatol.2003.11.005_BIB5","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1524-4725.1992.tb03295.x","article-title":"Treatment of glabellar frown lines with C. botulinum A exotoxin","volume":"18","author":"Carruthers","year":"1991","journal-title":"J Dermatol Surg Oncol"},{"key":"10.1016\/j.clindermatol.2003.11.005_BIB6","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1001\/archotol.1993.01880210108015","article-title":"Botulinum toxin for the treatment of hyperfunctional lines of the face","volume":"119","author":"Blitzer","year":"1993","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.clindermatol.2003.11.005_BIB7","first-page":"11","article-title":"The use of botulinum toxin to treat glabellar frown lines and other facial wrinkles","volume":"7","author":"Carruthers","year":"1994","journal-title":"Cosmet Dermatol"},{"key":"10.1016\/j.clindermatol.2003.11.005_BIB8","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1097\/00006534-199404001-00003","article-title":"Aesthetic indications for botulinum toxin injection","volume":"93","author":"Guryuron","year":"1994","journal-title":"Plast Reconstr Surg"},{"key":"10.1016\/j.clindermatol.2003.11.005_BIB9","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1097\/00006534-199407000-00009","article-title":"Botulinum toxin A for hyperkinetic facial lines","volume":"94","author":"Keen","year":"1994","journal-title":"Plast Reconstr Surg"},{"key":"10.1016\/j.clindermatol.2003.11.005_BIB10","series-title":"Therapy with botulinum toxin","first-page":"577","article-title":"Botulinum toxin in the treatment of glabellar frown lines and other facial wrinkles","author":"Carruthers","year":"1994"},{"key":"10.1016\/j.clindermatol.2003.11.005_BIB11","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1001\/archoto.123.4.389","article-title":"The management of hyperfunctional facial lines with botulinum toxin","volume":"123","author":"Blitzer","year":"1997","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.clindermatol.2003.11.005_BIB12","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/archotol.1997.01900030103013","article-title":"Patient selection in the treatment of glabellar wrinkles with botulinum toxin type A injection","volume":"123","author":"Pribitkin","year":"1997","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.clindermatol.2003.11.005_BIB13","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/S0190-9622(96)90016-X","article-title":"Botulinum A exotoxin use in clinical dermatology","volume":"34","author":"Carruthers","year":"1996","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2003.11.005_BIB14","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1080\/14764170260030117","article-title":"Botulinum toxins types A and B for brow furrows","volume":"4","author":"Lowe","year":"2002","journal-title":"J Cosmet Laser Ther"},{"key":"10.1016\/j.clindermatol.2003.11.005_BIB15","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1080\/14764170260030126","article-title":"Botulinum B treatment of the glabellar and frontalis regions","volume":"4","author":"Spencer","year":"2002","journal-title":"J Cosmet Laser Ther"},{"key":"10.1016\/j.clindermatol.2003.11.005_BIB16","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1046\/j.1524-4725.2002.02037.x","article-title":"Botulinum toxin type B for glabellar wrinkles","volume":"28","author":"Sadick","year":"2002","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.clindermatol.2003.11.005_BIB17","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1046\/j.1524-4725.2003.29017.x","article-title":"Comparison of botulinum toxin types A and B","volume":"29","author":"Matarasso","year":"2003","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.clindermatol.2003.11.005_BIB18","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1046\/j.1524-4725.2003.29082.x","article-title":"Comparison of botulinum toxins A and B in the aesthetic treatment of facial rhytides","volume":"29","author":"Sadick","year":"2003","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.clindermatol.2003.11.005_BIB19","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1046\/j.1524-4725.2002.29083.x","article-title":"Botulinum toxin type B","volume":"29","author":"Sadick","year":"2003","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.clindermatol.2003.11.005_BIB20","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1046\/j.1524-4725.2003.29122.x","article-title":"Prospective open-label study of botulinum toxin type B (Myobloc) at doses of 2, 400 and 3,000 U for the treatment of glabellar wrinkles","volume":"29","author":"Sadick","year":"2003","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.clindermatol.2003.11.005_BIB21","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1046\/j.1524-4725.2003.29132.x","article-title":"A double-blinded, randomized, placebo-controlled pilot study of the safety and efficacy of Myobloc (botulinum toxin type B)-purified neurotoxin complex for the treatment of crow's feet","volume":"29","author":"Baumann","year":"2003","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.clindermatol.2003.11.005_BIB22","series-title":"Therapy with botulinum toxin","first-page":"xxiii","article-title":"Historical perspective","author":"Schantz","year":"1994"},{"key":"10.1016\/j.clindermatol.2003.11.005_BIB23","series-title":"Therapy with botulinum toxin","first-page":"3","article-title":"The site and mechanism of action of botulinum neurotoxin","author":"Coffield","year":"1994"},{"key":"10.1016\/j.clindermatol.2003.11.005_BIB24","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0962-8924(97)01060-X","article-title":"Stages of regulated exocytosis","volume":"7","author":"Martin","year":"1997","journal-title":"Trends Cell Biol"},{"key":"10.1016\/j.clindermatol.2003.11.005_BIB25","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/365160a0","article-title":"Botulinum neurotoxin A selectively cleaves the synaptic protein SNAP-25","volume":"365","author":"Blasi","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.clindermatol.2003.11.005_BIB26","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1038\/359832a0","article-title":"Tetanus and botulinum-B neurotoxins block neurotransmitter release by proteolytic cleavage of synaptobrevin","volume":"359","author":"Schiavo","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.clindermatol.2003.11.005_BIB27","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/S1076-0512(98)00183-6","article-title":"Botulinum toxin type A for facial rejuvenation","volume":"24","author":"Lowe","year":"1998","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.clindermatol.2003.11.005_BIB28","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1212\/WNL.49.1.189","article-title":"Human response to botulinum toxin injection","volume":"49","author":"Sloop","year":"1997","journal-title":"Neurology"},{"issue":"suppl 5","key":"10.1016\/j.clindermatol.2003.11.005_BIB29","first-page":"S29","article-title":"The safety and efficacy of botulinum toxin type B in the treatment of patients with cervical dystonia","volume":"55","author":"Lew","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.clindermatol.2003.11.005_BIB30","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S0190-9622(96)90682-9","article-title":"Botulinum A exotoxin for glabellar folds","volume":"35","author":"Lowe","year":"1996","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2003.11.005_BIB31","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1067\/mjd.2002.121356","article-title":"A multicenter, double-blind, randomized, placebo-controlled study of the efficacy and safety of botulinum toxin type A in the treatment of glabellar lines","volume":"46","author":"Carruthers","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2003.11.005_BIB32","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1067\/mhn.2002.124706","article-title":"Botulinum toxin type B (MyoBloc) in the management of hyperkinetic facial lines","volume":"126","author":"Ramirez","year":"2002","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.clindermatol.2003.11.005_BIB33","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1046\/j.1524-4725.2003.29114.x","article-title":"A prospective, double-blind, randomized, parallel-group, dose-ranging study of botulinum toxin type A in female subjects with horizontal forehead rhytides","volume":"29","author":"Carruthers","year":"2003","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.clindermatol.2003.11.005_BIB33A","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1046\/j.1524-4725.2003.29124.x","article-title":"Botulinum toxin type B (Myobloc) versus botulinum toxin type A (Botox) frontalis study","volume":"29","author":"Flynn","year":"2003","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.clindermatol.2003.11.005_BIB34","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1067\/mjd.2002.124070","article-title":"Bilateral, double-blind, randomized comparison of 3 doses of botulinum toxin type A and placebo in patients with crow's feet","volume":"47","author":"Lowe","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2003.11.005_BIB35","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1007\/s00415-002-0929-4","article-title":"Botulinum toxin type B for treatment of axillar hyperhidrosis","volume":"249","author":"Dressler","year":"2002","journal-title":"J Neurol"},{"issue":"suppl","key":"10.1016\/j.clindermatol.2003.11.005_BIB36","doi-asserted-by":"crossref","first-page":"S191","DOI":"10.1097\/00002508-200211001-00012","article-title":"Review of the use of botulinum toxin for hyperhidrosis and cosmetic purposes","volume":"18","author":"Glogau","year":"2002","journal-title":"Clin J Pain"},{"key":"10.1016\/j.clindermatol.2003.11.005_BIB37","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1046\/j.1524-4725.2003.29123.x","article-title":"Botulinum toxin type B for dynamic glabellar rhytides refractory to botulinum toxin type A","volume":"29","author":"Alster","year":"2003","journal-title":"Dermatol Surg"}],"container-title":["Clinics in Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X0300107X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X0300107X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,7]],"date-time":"2019-02-07T12:21:38Z","timestamp":1549542098000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0738081X0300107X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,1]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2004,1]]}},"alternative-id":["S0738081X0300107X"],"URL":"https:\/\/doi.org\/10.1016\/j.clindermatol.2003.11.005","relation":{},"ISSN":["0738-081X"],"issn-type":[{"value":"0738-081X","type":"print"}],"subject":[],"published":{"date-parts":[[2004,1]]}}}